Ozempic may be able to treat kidney disease. This news has sent competitor DaVita into a tailspin as DVA stock plunges. More
Articles
The One Consumer Goods Stocks You Must Have In Your Portfolio
In terms of consumer defensive stocks, KHC stock remains a top pick for many investors with a long-term investing horizon. More
A Pivotal Moment For Electric Vehicle Adoption And Market Growth
Tesla leads the electric vehicle industry. Where it goes, others follow. And now it has successfully charted a course to EV cost parity. More
PLTR Warning: Why Now Is the Time to Steer Clear of This AI Play
There are plenty of ways investors can play the artificial intelligence boom, but PLTR stock could be among the riskiest right now. More
MA Stock Forecast: Where Is MasterCard Heading in 2024?
Boosted by strong consumer spending trends and its continued high levels of profitability, MA stock should outperform the market in 2024. More
